title: Global strategic partnerships in regenerative medicine.
abstract: The approach to research and development in biomedical science is changing. Increasingly, academia and industry seek to collaborate, and share resources and expertise, by establishing partnerships. Here, we explore the co-development partnership landscape in the field of regenerative medicine, focusing on agreements involving one or more private entities. A majority of the largest biopharmaceutical companies have announced strategic partnerships with a specific regenerative medicine focus, signifying the growth and widening appeal of this emerging sector.
authors.affiliation: The Oxford-UCL Centre for the Advancement of Sustainable Medical Innovation (CASMI), The University of Oxford, Oxford, OX3 7LG, UK. Electronic address: anna.french@casmi.org.uk.
authors.forename: Anna
authors.initials: A
authors.lastname: French
authors.affiliation: Harvard University Department of Stem Cell and Regenerative Biology, Cambridge, MA, 02138, USA.
authors.forename: Jane Y
authors.initials: JY
authors.lastname: Suh
authors.affiliation: Department of Genetics, Yale University, New Haven, CT 06520, USA; Section of Cardiovascular Medicine, Department of Internal Medicine, School of Medicine, Yale University, New Haven, CT 06520, USA; Yale Stem Cell Center, CT, 06520, USA.
authors.forename: Carol Y
authors.initials: CY
authors.lastname: Suh
authors.affiliation: Harvard University Department of Stem Cell and Regenerative Biology, Cambridge, MA, 02138, USA; Harvard Stem Cell Institute, Cambridge, MA, 02138, USA.
authors.forename: Lee
authors.initials: L
authors.lastname: Rubin
authors.affiliation: The Oxford-UCL Centre for the Advancement of Sustainable Medical Innovation (CASMI), The University of Oxford, Oxford, OX3 7LG, UK.
authors.forename: Richard
authors.initials: R
authors.lastname: Barker
authors.affiliation: Sartorius Stedim, Göttingen, 37079, Germany.
authors.forename: Kim
authors.initials: K
authors.lastname: Bure
authors.affiliation: Harvard Stem Cell Institute, Cambridge, MA, 02138, USA.
authors.forename: Brock
authors.initials: B
authors.lastname: Reeve
authors.affiliation: Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Nuffield Orthopaedic Centre, University of Oxford, Oxford, OX3 7LD, UK; The Oxford-UCL Centre for the Advancement of Sustainable Medical Innovation (CASMI), The University of Oxford, Oxford, OX3 7LG, UK; Harvard Stem Cell Institute, Cambridge, MA, 02138, USA; Centre for Behavioral Medicine, UCL School of Pharmacy, University College London, London, WC1N 1AX, UK.
authors.forename: David A
authors.initials: DA
authors.lastname: Brindley
mesh_terms: D003299:Cooperative Behavior; D004345:Drug Industry; D055818:Public-Private Sector Partnerships / Q000458:organization & administration* / Q000639:trends; D044968:Regenerative Medicine / Q000379:methods* / Q000639:trends; D012106:Research / Q000458:organization & administration* / Q000639:trends; D014495:Universities
keywords: cell therapies; regenerative medicine; stem cells; strategic partnerships; translation